drugset / Trial / NCT03027934
A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response
RandomizedCrossoverOpen-labelBasic science
Summary
The overall objective of this study is to assess P2Y12 inhibition ex vivo in blood samples obtained from diabetic subjects who will be administered one of the two P2Y12 antagonists in a cross-over design.
Timeline
- Start
- 2017-08-28
- Primary completion
- 2017-10-31
- Completion
- 2017-10-31
Outcome
Outcome not reported
Stopped (Enrollment): “Study population difficult to recruit”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prasugrel | Small molecule | 10 mg | — |
| Comparator | Ticagrelor | Small molecule | 90 mg | — |